{
    "clinical_study": {
        "@rank": "85517", 
        "arm_group": {
            "arm_group_label": "Cohort"
        }, 
        "brief_summary": {
            "textblock": "This observational survey study will capture all renal transplant patients in Serbia who are\n      currently receiving CellCept (mycophenolate mofetil) as part of their immunosuppressive\n      protocol."
        }, 
        "brief_title": "An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients", 
        "completion_date": {
            "#text": "January 2011", 
            "@type": "Actual"
        }, 
        "condition": "Kidney Transplantation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients, >/= 18 years of age\n\n          -  Recipients of renal allograft\n\n          -  Patients receiving CellCept\n\n        Exclusion Criteria:\n\n          -  N/A"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Renal allograft recipients receiving CellCept as part of their immunosuppressive protocol"
            }
        }, 
        "enrollment": {
            "#text": "414", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01707550", 
            "org_study_id": "ML25048"
        }, 
        "intervention_browse": {
            "mesh_term": "Mycophenolate mofetil"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 5, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Belgrade", 
                        "country": "Serbia", 
                        "zip": "11000"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "NIS", 
                        "country": "Serbia", 
                        "zip": "18000"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Novi Sad", 
                        "country": "Serbia", 
                        "zip": "21000"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "Serbia"
        }, 
        "number_of_groups": "1", 
        "official_title": "Observational, Non-interventional Survey of Renal Allograft Recipients Receiving CellCept as Part of Their Immunosuppressive Protocol", 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Sebia: Medicines and Medical Devices Agency"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Average dose of CellCept used in immunosuppressive protocols in Serbia", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "Average dose of concomitant immunosuppressive drugs", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01707550"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Average duration of post-transplant period for patients in Serbia receiving CellCept", 
            "safety_issue": "No", 
            "time_frame": "9 months"
        }, 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2009", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}